Roger Henriksson
University Hospital of Umeå · 583 works · 24,391 citations · h-index 65
Top works
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- Genome-wide association study identifies five susceptibility loci for glioma
- Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
- Detectable clonal mosaicism and its relationship to aging and cancer
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- Parotid gland function during and following radiotherapy of malignancies in the head and neck
- EANO guidelines for the diagnosis and treatment of meningiomas
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
- Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
- FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
- Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
- Familial brain tumours—genetics or environment? A nationwide cohort study of cancer risk in spouses and first‐degree relatives of brain tumour patients
- Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer.
- The creation of protection and hope in patients with malignant brain tumours
- The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
- Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, α-interferon (leucocyte) and tamoxifen
- Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial